The UK’s Medicines and
Healthcare products Regulatory
Agency (MHRA) has alerted
pharmacies, dispensing clinics and
wholesalers to return stocks of
Imigran injectable.
GSK UK has recalled five batches
of the migraine headache
medication due to a manufacturing
fault which causes a small number
of needles to protrude from the
protective shield.
It’s not a patient level recall,
with the number of affected
items thought to be very small
and the risk to members of the
public finding an affected syringe
“extremely low”.
However there’s a slight risk of
infection from an unprotected
needle, with patients urged to
take extra care when using these
syringes.
Australian stocks are unaffected.The above article was sent to subscribers in Pharmacy Daily's issue from 31 Oct 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Oct 13
THE 87-year-old Amcal group has refreshed its brand tagline to ‘For you, for life’, as unveiled yesterday to over 240 members, suppliers and partners at the group’s national retail conference in Sydney.
AMID yesterday’s Amcal brand refresh announcement (see page one), parent company Sigma Healthcare is also readying for the 01 Jul start of its wholesale supply contract with Chemist Warehouse Group, worth at least $3 billion in revenue in the first full year (PD 06 Jun 2023).
OVER a quarter of a million people have sbeen vaccinated against influenza this year through community pharmacies in Queensland, reported the Pharmacy Guild of Australia.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.